Yucera (玉汝成) Raises Series B for Integrated Digital Dentistry Platform

Shenzhen Yurucheng Dental Materials — known commercially as Yucera (玉汝成) — has raised a Series B round, according to funding data tracked by VeilStrat. The round is dated September 10, 2026.

Who Participated

The Series B included participation from:

Suikai Investment (穗开投资)
Zhuhai Gaoke Jintou (珠海高科金投)
Aeonmed (谊安医疗)

The round did not disclose a named lead investor, and the funding amount was not disclosed in the available data.

What Yucera Does

Founded in 2017 and headquartered in Shenzhen, Yucera develops and manufactures dental restorative materials, most notably zirconia blocks, alongside its own line of digital dentistry equipment. That equipment portfolio spans:

Milling machines
Sintering and porcelain furnaces
Lab scanners
Intraoral scanners

Together, these products are positioned to give dental labs and clinics an integrated workflow running from scanning through to finished restorations. The company supports this offering with a smart factory in Shenzhen.

Regulatory Position and Global Reach

Yucera's products carry FDA, EU CE and ISO 13485 certifications — a combination that matters for any acquirer or strategic partner evaluating cross-border distribution potential. The company states that its products reach customers in more than 150 countries, with overseas markets generating over 70% of revenue.

That revenue mix is notable. A dental materials and equipment manufacturer with the majority of its sales outside its home market has already cleared many of the regulatory, logistics and channel hurdles that typically slow international expansion in medtech hardware.

Why the Round Matters

The Series B comes as dental labs and clinics continue to shift toward digital workflows, replacing manual processes with scanning, milling and sintering equipment. Yucera's strategy of pairing consumable restorative materials with the machines that process them creates a recurring-revenue dynamic: equipment placements drive ongoing material sales.

For strategic acquirers, that combination — certified materials plus the hardware ecosystem that consumes them — represents an installed-base opportunity rather than a one-time capital sale.

What Was Not Disclosed

The available data does not include the funding amount, a named lead investor, or a source link for the announcement. Those details were not included in the round information and are therefore not reported here.

Acquisition Angle

Yucera sits at the intersection of two consolidating categories: dental consumables and digital dentistry equipment. Companies with FDA, CE and ISO 13485 certifications, a smart manufacturing base in Shenzhen, and more than 70% of revenue from overseas markets are natural targets for larger dental platforms seeking vertically integrated material-plus-equipment offerings.

The Series B adds fresh capital to scale that integrated workflow — and gives the company a larger footprint to negotiate from in any future strategic conversation.